- a strong leadership team,
- proven product-market fit, and
- a clear go-to-market strategy.
September 4, 2017
A killer pitch deck sounds like a story by design. It is meant to help you step back from the details of your business or new product, to tell a compelling story to an investor. It reads as simple as this: “We are a unique team, excited to solve a big and hard problem. We came up with a sustainably differentiated solution. As a result, we are gaining solid traction, which we monetize fairly. So our financials look extremely promising but to get there, we need a reasonable amount of funding. We have a credible plan to generate significant returns for our investors.”Read More
February 3, 2017
When a due diligence is appropriate, we ask the entrepreneur to make a data room available to the due diligence team. Through a review of the material in the data room and discussions with the CEO, exec team and references, the due diligence lead is able to cover the key aspects of the due diligence: team, business, financing, and match with Mighty Capital.Read More
In venture capital, the increasing disruption by mega-funds is driving many VCs into the classic innovator’s dilemma: I need to raise bigger funds to survive, but doing so will eventually dilute my returns which will ultimately kill me. The now-classic example is SoftBank who’s founder Masayoshi Son raised $100 billion dollars to invest “unlimited cash” in innovation-crazed companies. Based on my experience navigating three different innovator’s dilemmas, I see two main reasons for this disruptive trend and three ways VC firms might respond. As we’re all navigating towards a new normal, post-COVID-19, these responses will define a new industry direction, and I believe the natural endpoint will be increased fund consolidation activity.Read More
SC Moatti shares some insights and observations on what it takes to be a true value adding member, specifically at an early-stage company. Plus, what’s required during deciding moments, such as fundraising, CEO transition, insolvency, and exits.Read More
Mighty Capital’s Jennifer Vancini sat down recently with Scott Orn, host of the engaging Founders and Friends podcast series, to discuss product-led VC investing. In this series, Scott interviews top VCs, founders and advisors to share their insights on the startup journey. Jennifer describes how Mighty Capital leverages our network of product professionals, through Products That Count and our partners, to evaluate investments and drive value for portfolio companies and investors. She and Scott share laughs and insights as they compare experiences in this dynamic, complicated process.Read More
February 3, 2020
This article was originally published on Inc Magazine and discusses how as an entrepreneur, your startup needs more than just cash and your investors should help. It features Mighty Capital alongside leading VC firms like Redpoint Ventures and Andreessen Horowitz.Read More
July 12, 2019
Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scaleRead More
June 27, 2019
An effective branding strategy requires seeing your entire constituent universe and transmitting a constant, cohesive and comprehensive values message.Read More
May 21, 2019
Cancer is smart. Yes, you read that right.
The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.
To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.Read More